Selected research
Industry Research
High-Density Lipoprotein (HDL) Cholesterol Test Industry Research Report 2026
Market perspective
The global High-Density Lipoprotein (HDL) Cholesterol Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the High-Density Lipoprotein (HDL) Cholesterol Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the High-Density Lipoprotein (HDL) Cholesterol Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the High-Density Lipoprotein (HDL) Cholesterol Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of High-Density Lipoprotein (HDL) Cholesterol Test include Quest Diagnostics Incorporated, Cell Biolabs, Bio-Reference Laboratories, Spectra Laboratories, Eurofins Scientific, Randox Laboratories, Synlab International GmbH, Thermo Fisher Scientific and Clinical Reference Laboratory, Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global High-Density Lipoprotein (HDL) Cholesterol Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to High-Density Lipoprotein (HDL) Cholesterol Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
High-Density Lipoprotein (HDL) Cholesterol Test Market by Company
Quest Diagnostics Incorporated
Cell Biolabs
Bio-Reference Laboratories
Spectra Laboratories
Eurofins Scientific
Randox Laboratories
Synlab International GmbH
Thermo Fisher Scientific
Clinical Reference Laboratory, Inc.
Abbott Diagnostics
Roche
General Life Biotechnology
PTS Diagnostics
Beckman Coulter
Bioptik
BeneCheck
ACON
Quest
Accutech
ZCALSON
Akers Biosciences
High-Density Lipoprotein (HDL) Cholesterol Test Segment by Type
Product
Service
High-Density Lipoprotein (HDL) Cholesterol Test Segment by Application
Hospital
Clinic
Household
High-Density Lipoprotein (HDL) Cholesterol Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High-Density Lipoprotein (HDL) Cholesterol Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of High-Density Lipoprotein (HDL) Cholesterol Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High-Density Lipoprotein (HDL) Cholesterol Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of High-Density Lipoprotein (HDL) Cholesterol Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Product
- Service
Applications
- Hospital
- Clinic
- Household
Companies covered
- Quest Diagnostics Incorporated
- Cell Biolabs
- Bio-Reference Laboratories
- Spectra Laboratories
- Eurofins Scientific
- Randox Laboratories
- Synlab International GmbH
- Thermo Fisher Scientific
- Clinical Reference Laboratory, Inc.
- Abbott Diagnostics
- Roche
- General Life Biotechnology
- PTS Diagnostics
- Beckman Coulter
- Bioptik
- BeneCheck
- ACON
- Quest
- Accutech
- ZCALSON
- Akers Biosciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 High-Density Lipoprotein (HDL) Cholesterol Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Product
- 2.2.3 Service
- 2.3 High-Density Lipoprotein (HDL) Cholesterol Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Household
- 2.4 Assumptions and Limitations
3 High-Density Lipoprotein (HDL) Cholesterol Test Breakdown Data by Type
- 3.1 Global High-Density Lipoprotein (HDL) Cholesterol Test Historic Market Size by Type (2021-2026)
- 3.2 Global High-Density Lipoprotein (HDL) Cholesterol Test Forecasted Market Size by Type (2027-2032)
4 High-Density Lipoprotein (HDL) Cholesterol Test Breakdown Data by Application
- 4.1 Global High-Density Lipoprotein (HDL) Cholesterol Test Historic Market Size by Application (2021-2026)
- 4.2 Global High-Density Lipoprotein (HDL) Cholesterol Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global High-Density Lipoprotein (HDL) Cholesterol Test Market Perspective (2021-2032)
- 5.2 Global High-Density Lipoprotein (HDL) Cholesterol Test Growth Trends by Region
- 5.2.1 Global High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 High-Density Lipoprotein (HDL) Cholesterol Test Historic Market Size by Region (2021-2026)
- 5.2.3 High-Density Lipoprotein (HDL) Cholesterol Test Forecasted Market Size by Region (2027-2032)
- 5.3 High-Density Lipoprotein (HDL) Cholesterol Test Market Dynamics
- 5.3.1 High-Density Lipoprotein (HDL) Cholesterol Test Industry Trends
- 5.3.2 High-Density Lipoprotein (HDL) Cholesterol Test Market Drivers
- 5.3.3 High-Density Lipoprotein (HDL) Cholesterol Test Market Challenges
- 5.3.4 High-Density Lipoprotein (HDL) Cholesterol Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top High-Density Lipoprotein (HDL) Cholesterol Test Players by Revenue
- 6.1.1 Global Top High-Density Lipoprotein (HDL) Cholesterol Test Players by Revenue (2021-2026)
- 6.1.2 Global High-Density Lipoprotein (HDL) Cholesterol Test Revenue Market Share by Players (2021-2026)
- 6.2 Global High-Density Lipoprotein (HDL) Cholesterol Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of High-Density Lipoprotein (HDL) Cholesterol Test Head Office and Area Served
- 6.4 Global High-Density Lipoprotein (HDL) Cholesterol Test Players, Product Type & Application
- 6.5 Global High-Density Lipoprotein (HDL) Cholesterol Test Manufacturers Established Date
- 6.6 Global High-Density Lipoprotein (HDL) Cholesterol Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America High-Density Lipoprotein (HDL) Cholesterol Test Market Size (2021-2032)
- 7.2 North America High-Density Lipoprotein (HDL) Cholesterol Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2021-2026)
- 7.4 North America High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe High-Density Lipoprotein (HDL) Cholesterol Test Market Size (2021-2032)
- 8.2 Europe High-Density Lipoprotein (HDL) Cholesterol Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2021-2026)
- 8.4 Europe High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific High-Density Lipoprotein (HDL) Cholesterol Test Market Size (2021-2032)
- 9.2 Asia-Pacific High-Density Lipoprotein (HDL) Cholesterol Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America High-Density Lipoprotein (HDL) Cholesterol Test Market Size (2021-2032)
- 10.2 South America High-Density Lipoprotein (HDL) Cholesterol Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2021-2026)
- 10.4 South America High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa High-Density Lipoprotein (HDL) Cholesterol Test Market Size (2021-2032)
- 11.2 Middle East & Africa High-Density Lipoprotein (HDL) Cholesterol Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa High-Density Lipoprotein (HDL) Cholesterol Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Quest Diagnostics Incorporated
- 12.1.1 Quest Diagnostics Incorporated Company Information
- 12.1.2 Quest Diagnostics Incorporated Business Overview
- 12.1.3 Quest Diagnostics Incorporated Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.1.4 Quest Diagnostics Incorporated High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.1.5 Quest Diagnostics Incorporated Recent Developments
- 12.2 Cell Biolabs
- 12.2.1 Cell Biolabs Company Information
- 12.2.2 Cell Biolabs Business Overview
- 12.2.3 Cell Biolabs Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.2.4 Cell Biolabs High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.2.5 Cell Biolabs Recent Developments
- 12.3 Bio-Reference Laboratories
- 12.3.1 Bio-Reference Laboratories Company Information
- 12.3.2 Bio-Reference Laboratories Business Overview
- 12.3.3 Bio-Reference Laboratories Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.3.4 Bio-Reference Laboratories High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.3.5 Bio-Reference Laboratories Recent Developments
- 12.4 Spectra Laboratories
- 12.4.1 Spectra Laboratories Company Information
- 12.4.2 Spectra Laboratories Business Overview
- 12.4.3 Spectra Laboratories Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.4.4 Spectra Laboratories High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.4.5 Spectra Laboratories Recent Developments
- 12.5 Eurofins Scientific
- 12.5.1 Eurofins Scientific Company Information
- 12.5.2 Eurofins Scientific Business Overview
- 12.5.3 Eurofins Scientific Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.5.4 Eurofins Scientific High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.5.5 Eurofins Scientific Recent Developments
- 12.6 Randox Laboratories
- 12.6.1 Randox Laboratories Company Information
- 12.6.2 Randox Laboratories Business Overview
- 12.6.3 Randox Laboratories Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.6.4 Randox Laboratories High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.6.5 Randox Laboratories Recent Developments
- 12.7 Synlab International GmbH
- 12.7.1 Synlab International GmbH Company Information
- 12.7.2 Synlab International GmbH Business Overview
- 12.7.3 Synlab International GmbH Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.7.4 Synlab International GmbH High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.7.5 Synlab International GmbH Recent Developments
- 12.8 Thermo Fisher Scientific
- 12.8.1 Thermo Fisher Scientific Company Information
- 12.8.2 Thermo Fisher Scientific Business Overview
- 12.8.3 Thermo Fisher Scientific Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.8.4 Thermo Fisher Scientific High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.8.5 Thermo Fisher Scientific Recent Developments
- 12.9 Clinical Reference Laboratory, Inc.
- 12.9.1 Clinical Reference Laboratory, Inc. Company Information
- 12.9.2 Clinical Reference Laboratory, Inc. Business Overview
- 12.9.3 Clinical Reference Laboratory, Inc. Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.9.4 Clinical Reference Laboratory, Inc. High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.9.5 Clinical Reference Laboratory, Inc. Recent Developments
- 12.10 Abbott Diagnostics
- 12.10.1 Abbott Diagnostics Company Information
- 12.10.2 Abbott Diagnostics Business Overview
- 12.10.3 Abbott Diagnostics Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.10.4 Abbott Diagnostics High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.10.5 Abbott Diagnostics Recent Developments
- 12.11 Roche
- 12.11.1 Roche Company Information
- 12.11.2 Roche Business Overview
- 12.11.3 Roche Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.11.4 Roche High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.11.5 Roche Recent Developments
- 12.12 General Life Biotechnology
- 12.12.1 General Life Biotechnology Company Information
- 12.12.2 General Life Biotechnology Business Overview
- 12.12.3 General Life Biotechnology Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.12.4 General Life Biotechnology High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.12.5 General Life Biotechnology Recent Developments
- 12.13 PTS Diagnostics
- 12.13.1 PTS Diagnostics Company Information
- 12.13.2 PTS Diagnostics Business Overview
- 12.13.3 PTS Diagnostics Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.13.4 PTS Diagnostics High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.13.5 PTS Diagnostics Recent Developments
- 12.14 Beckman Coulter
- 12.14.1 Beckman Coulter Company Information
- 12.14.2 Beckman Coulter Business Overview
- 12.14.3 Beckman Coulter Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.14.4 Beckman Coulter High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.14.5 Beckman Coulter Recent Developments
- 12.15 Bioptik
- 12.15.1 Bioptik Company Information
- 12.15.2 Bioptik Business Overview
- 12.15.3 Bioptik Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.15.4 Bioptik High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.15.5 Bioptik Recent Developments
- 12.16 BeneCheck
- 12.16.1 BeneCheck Company Information
- 12.16.2 BeneCheck Business Overview
- 12.16.3 BeneCheck Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.16.4 BeneCheck High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.16.5 BeneCheck Recent Developments
- 12.17 ACON
- 12.17.1 ACON Company Information
- 12.17.2 ACON Business Overview
- 12.17.3 ACON Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.17.4 ACON High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.17.5 ACON Recent Developments
- 12.18 Quest
- 12.18.1 Quest Company Information
- 12.18.2 Quest Business Overview
- 12.18.3 Quest Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.18.4 Quest High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.18.5 Quest Recent Developments
- 12.19 Accutech
- 12.19.1 Accutech Company Information
- 12.19.2 Accutech Business Overview
- 12.19.3 Accutech Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.19.4 Accutech High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.19.5 Accutech Recent Developments
- 12.20 ZCALSON
- 12.20.1 ZCALSON Company Information
- 12.20.2 ZCALSON Business Overview
- 12.20.3 ZCALSON Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.20.4 ZCALSON High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.20.5 ZCALSON Recent Developments
- 12.21 Akers Biosciences
- 12.21.1 Akers Biosciences Company Information
- 12.21.2 Akers Biosciences Business Overview
- 12.21.3 Akers Biosciences Revenue in High-Density Lipoprotein (HDL) Cholesterol Test Business (2021-2026)
- 12.21.4 Akers Biosciences High-Density Lipoprotein (HDL) Cholesterol Test Product Portfolio
- 12.21.5 Akers Biosciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst